「d2」の検索結果
400件:41~45件目を表示
-

March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -

ミケランLA点眼液 添付文書 2022年3月改訂 TD75X2B17
1%〉 プラスチック点眼容器:2.5mL×10本 〈ミケランLA点眼液2%〉 プラスチック点眼容器:2.5mL×10本 23. 主要文献 1)社内資料:臨床薬理試験 (2007年4月18日承認、 CTD2.7.6.1) 2)川瀬和秀 ほか:日本眼科学会雑誌. 2010;114(11):976-982. 3)社内資料:血漿中カルテオロール濃度の比較 (2007年4月18 日承認、CTD2.7.6.3...
https://www.senju.co.jp/system/files/product_other_file/2022-03/MKLA_17_20220330_0.pdf -

Business Activities | About Senju | SENJU Pharmaceutical
Based on a sense of mission to contribute to the health of the eyes of people around the world, and a development policy that puts top priority on safety, we have always taken a pioneering path in oph
http://www.senju.co.jp/english/about/business/ -

千寿製薬について | 千寿製薬株式会社
CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Production system Quality policy
http://www.senju.co.jp/english/about/ -

Production | About Senju | SENJU Pharmaceutical
Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject
http://www.senju.co.jp/english/about/production.html